CVS Group (LON:CVSG) Announces Earnings Results

CVS Group (LON:CVSG) released its earnings results on Thursday. The company reported GBX 85.60 earnings per share for the quarter, Digital Look Earnings reports. CVS Group had a return on equity of 5.35% and a net margin of 2.31%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Stock Performance

Shares of LON:CVSG traded down GBX 81 on Thursday, reaching GBX 1,221. 20,944,436 shares of the company’s stock were exchanged, compared to its average volume of 991,069. The company has a fifty day moving average of GBX 1,289.88 and a 200-day moving average of GBX 1,230. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648. The company has a market capitalization of £829.91 million, a price-to-earnings ratio of 17.72, a PEG ratio of 1.77 and a beta of 1.07. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34.

Insider Activity

In related news, insider Joanne Shaw purchased 1,592 shares of CVS Group stock in a transaction that occurred on Monday, August 10th. The shares were acquired at an average price of GBX 1,287 per share, with a total value of £20,489.04. Also, insider Robin Alfonso bought 768 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Over the last ninety days, insiders acquired 3,860 shares of company stock worth $4,956,696. Corporate insiders own 1.48% of the company’s stock.

Analyst Ratings Changes

CVSG has been the subject of a number of research reports. Jefferies Financial Group increased their target price on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a research note on Friday, July 31st. Shore Capital Group reissued a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a research report on Thursday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a research note on Monday, July 27th. Finally, Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a research note on Thursday. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,666.67.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.